Tirzepatide 5mg

Tirzepatide – Dual GIP and GLP-1 Receptor Agonist with Exceptional Research Potential in Metabolism, Insulin Regulation, and Obesity

Tirzepatide is a synthetic peptide composed of 39 amino acids that combines the actions of two incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This dual activity makes it a unique and promising tool for research in glucose metabolism, weight control, and insulin sensitivity.

Studies indicate that Tirzepatide can improve glycemic control, reduce body weight, and enhance insulin efficiency without significantly increasing the risk of hypoglycemia. Research also suggests its potential in addressing insulin resistance, metabolic syndrome, and type 2 diabetes. Additionally, it promotes satiety and reduces food intake, making it valuable in the study of appetite regulation and body composition.

Key Research Benefits of Tirzepatide:

• Dual activation of GIP and GLP-1 receptors

• Improved insulin sensitivity

• Support for body weight regulation

• Reduction of blood glucose levels

• Potential use in obesity and type 2 diabetes research

Usage

This product is intended solely for scientific and laboratory research purposes. It is not a drug, supplement, or treatment for human or veterinary use.

Tirzepatide Dosage:

Dosage and application of Tirzepatide are determined by laboratory professionals according to the research objectives and protocols.

Form

Lyophilized powder.

Peptide Reconstitution and Storage

Store lyophilized peptides at -20°C. A suitable solvent is 0.9% sodium chloride (NaCl) physiological solution.

Once reconstituted, store the peptide at 2–8°C and use within the recommended timeframe according to laboratory standards.